Regeneron Pharmaceuticals, headquartered near Tarrytown, N.Y., is just one of the companies now working to identify and reproduce large quantities of antibodies that could prevent or treat COVID-19. Senior R&D Specialist Kristen Pascal works on COVID-19 research for Regeneron. (Rani Levy/Regeneron Pharmaceuticals)